DIRS.INFO The most relevant business & tech news

The Many Links Between Project 2025 and Trump’s WorldFormer president Donald J. Trump has repeatedly claimed that he had nothing to do with Project 2025, the Heritage Foundation’s conservative policy initiative to reshape the federal government. But Project 2025 has numerous ties to Mr. Trump and his campaign, a New York Times analysis has found. L. ZorcJump to the full list of authors, editors and contributorsSpokespeople for Project 2025 have denied that they are advocates for any particular candidate, and Project 2025 has no official ties to the Trump campaign. To limit the appearance of connection, Mr. Trump’s transition team has been excluding prominent people linked to Project 2025 from its preparations. Project 2025 additionally calls for the dismantling of the federal Education Department, which Mr. Trump has also pledged to do.

Persons: Donald J, Trump, Kevin D, Roberts, Edwin J, Trump’s, Albrecht Mark Albrecht, Anderson J, Anderson Jeff Anderson, Anton Michael Anton, Antoni A, Arthur Andrew Arthur, Atkins Paul Atkins, Axelrod Julie Axelrod, Bacon James Bacon, Baehr James Baehr, Baker E, Erik Baptist, Bennett J, Berlau, Berman Russell Berman, Bhagat S, Billy Stephen Billy, Bishop Brad Bishop, Bixby J, Blackman J, Jim, Bovard, Bowman Matt Bowman, Bradbury Steven G, Bradbury, Brashers J, Bronitsky Jonathan Bronitsky, Brosnan Kyle Brosnan, Brown R, Burkett Robert Burkett, Burley Michael Burley, J, Butcher, Mark Buzby, Byfield, Byrd David Byrd, Campau Anthony Campau, Carroll O, Cass B, Cavanaugh Brian J, Cavanaugh, Chretien Spencer Chretien, Christensen V, Coates Victoria Coates, Ellie Cohanim, Cohen Ezra Cohen, Colby Elbridge Colby, Comstock Earl Comstock, Correnti Lisa Correnti, Crowley Monica Crowley, Cunliffe Laura Cunliffe, Sergio de la, Ruyter, Del, Dennis Irv Dennis, DeVore J, Dickerson, Ding Michael Ding, Dodson, Dave Dorey, Eden T, Edgar Troy Edgar, Edlow Joseph Edlow, Ehlinger Jen Ehlinger, Ehrett, Eichamer Kristen Eichamer, Eitel Robert S, Estrada, Farkish Thompson, Feere Jon Feere, Fisher Travis Fisher, Fishman George Fishman, Ford Leslie Ford, Friedman Aharon Friedman, Frohnen J, Frushone Joel Frushone, Fulton Finch Fulton, Gabel Caleigh Gabel, Gaiser Alexandra Gaiser, Garza P, Geller, Gillen J, Gilmore James S, Gilmore, Ginn Vance Ginn, Alma Golden, Gore, D, Greenberg Dan Greenberg, Greenway, Greszler, DJ Gribbin, Grisedale Garrison Grisedale, Grogan Joseph Grogan, Guernsey J, Gunter Jeffrey Gunter, Guy Joe Guy, Guzman Joseph Guzman, Hanania, Harlow David Harlow, Harvey Derek Harvey, Hayes, Edie Heipel, Hemenway Troup, Hoekstra Pete Hoekstra, Hoffman T, Homan Tom Homan, Horner Chris Horner, Howell Mike Howell, Huber Valerie Huber, Hughes Andrew Hughes, Humire, Iacovella, Israel K, Ivory R, Jankowski Roman Jankowski, Jay Carafano James Jay Carafano, Jones, Kao J, Kelson Jared M, Kelson, Kilmartin Ali Kilmartin, Kirchner Julie Kirchner, Kish, Klukowski Kenneth A, Adam Korzeniewski, Bethany Kozma, Kozma Matthew Kozma, Krein, Kurtz, LaCerte David LaCerte, Larkin P, Lawrence Paul Lawrence, Lawrence III James R, Lawrence III, Legates David Legates, Lewis B, Lieberman J, Ligon John Ligon, Lim Evelyn Lim, Lorraine Viña Morgan Lorraine Viña, Loyola Mario Loyola, G, Malcolm J, Masterman, Matthews Earl Matthews, Mauler, McCall, McCotter Trent McCotter, Meadowcroft Micah Meadowcroft, Meese, Melugin, Mermoud, Miller, Mitchell K, Kevin E, C, Morell Clare Morell, Morgan Mark Morgan, Morgen Hunter Morgen, Morrison J, Moy, Murray R, Nabil M, Nasi L, Niemeyer Lucian Niemeyer, Nazak, Milan Nikolich, Nuebel, Kathy Nuebel Kovarik, Orr, Owcharenko Schaefer Nina Owcharenko Schaefer, O’Brien, Michael, Pedersen Leah Pedersen, Pillsbury Michael Pillsbury, Pizzella Patrick Pizzella, Porter K, Kevin Preskenis, Pryor Pam Pryor, Pyle J, Ratcliffe John Ratcliffe, Ray Paul Ray, Reddan J, Richards J, Richardson Jordan Richardson, Richwine Jason Richwine, Ries Lora Ries, Rios, Mark Robeck, Rockas James Rockas, Royce R, Rubinstein Reed Rubinstein, Ruger, Ruse, Sadler J, Sanders, Carla Sands, Sauve, Schaefer, Schuck Matt Schuck, Schwab Justin Schwab, Schweppe, Scribner, Selnick Darin Selnick, Sewell K, Sgamma, Sharp J, Shelton Judy Shelton, Simington Nathan Simington, Smith Loren Smith, Smith J, Spencer A, Spero Adrienne Spero, Spoehr, Onge C, Stanley Chris Stanley, Stannard Paula M, Stannard, Steiger William Steiger, Stein, Stephany Saunders, Stewart Corey Stewart, Stull Mari Stull, Sullivan Katharine T, Sullivan, Swearingen, Sweeney R, Swope Robert Swope, Szabo Aaron Szabo, Katy Talento, Tata Tony Tata, Thurman Todd Thurman, Tolman K, Tonnessen Kayla M, Trotter, Troy C, Tufts Clayton Tufts, Valdez, Mark Vandroff, Vaughan J, Venable, Vollmer, Wallace DeWitt C, Wallace DeWitt, Walsh E, Walsh Erin Walsh, Ward, Waters, William Salter M, Williams Michael Williams, Wolff J, Wolfson Jonathan Wolfson, Alexei Woltornist, Wuco Frank Wuco, Ybarra J, Zadrozny John Zadrozny, ”, John McEntee, James Bacon, Reagan, Howard Lutnick, Joseph R, Biden Jr, Dennis Dean Kirk, Kirk, Mr, “, JD Vance, Roberts’s, Kevin Roberts, Rick Dearborn, Russell T, Evan Vucci, Paul Dans, Dans, Ken Cuccinelli, Christopher Miller, Chip Somodevilla, Samuel Corum, The New York Times Christopher Miller, Biden, Miller’s, Skinner, Gene Hamilton, Hamilton, ” President Biden, Ben Carson, Todd Heisler, Jonathan Berry, Carson, Stephen Moore, Peter Navarro, Navarro, Karen Kerrigan, Ken Cedeno, Edwin Feulner, Robert Bowes Organizations: Heritage, New York Times, Mr, Leadership, Trump, Ivory, Loyola, Poole, Royce, Tufts, Heritage Foundation, The New, The New York Times, Washington Post, Associated Press, White, White House, Republican, Management, Defense , Homeland Security, State, Homeland Security Department, Defense Department, Twitter, State Department, Justice Department, ”, federal Education Department, Urban Development Department, Republican National Convention, Center for American Progress, Small Business Administration, Small Business, Entrepreneurship Council, Federal Communications Commission, Federal Trade Commission Locations: Guernsey, The New York, Palm Beach, Fla, Southern

May 8 (Reuters) - A case brought by anti-abortion groups seeking to ban the abortion pill mifepristone nationwide will be heard next week by a panel of three deeply conservative judges hostile to abortion rights, a federal appeals court revealed on Monday. Circuit Court of Appeals panel in New Orleans on May 17 to overturn a court order that suspended the federal government's approval of mifepristone. The U.S. Supreme Court put that order on hold, meaning that mifepristone remains available while the case is appealed. In 2021, Ho was in the majority in a 2-1 ruling refusing to block Texas's six-week abortion ban. Wilson, another Trump appointee, as a state legislator voted to ban abortion once fetal cardiac activity is detected, around six weeks.

☆ Comstock Act: The 150-year-old chastity law that may be the next big fight over abortion
▼ + stars: | 2023-04-28 | by ( Tierney Sneed | ) edition.cnn.com time to read: +15 min

“Comstock is really the backdoor way to remove access to abortion across the whole country,” said Greer Donley, a University of Pittsburgh Law School professor who specializes in abortion law. Severino argued that, at least when it comes to the Comstock Act’s prohibitions on mailing abortion pills, Congress is well within its powers to regulate those shipments. Several towns, some in New Mexico and elsewhere, have passed local ordinances that cite the Comstock Act and prohibit business within those jurisdictions from shipping or receiving items used for abortions in the mail, as covered by the Comstock Act. The lawsuits in New Mexico state court that those ordinances have prompted may provide for another opportunity for courts to elaborate on what the Comstock Act means. The Supreme Court, in the emergency order it issued last week, did not say anything about the Comstock Act.

The Supreme Court temporarily halted court orders that would have impacted the availability of an abortion drug. A Supreme Court decision Friday to keep available — for now — the widely used abortion pill mifepristone was met with relief from one side of the debate, disappointment from the other and a vow from both to keep fighting. Maura Healey of Massachusetts called the court’s decision a “victory” for abortion patients and providers. While statements of muted celebration poured in from elected Democrats and groups supporting abortion rights, comment from Republicans and anti-abortion groups was noticeably sparser. Attorney General Andrew Bailey of Missouri, who opposes abortion, said through a spokesman that the decision was a disappointment.

☆ Antiabortion group says appeals court lacks authority to block Texas abortion pill ruling
▼ + stars: | 2023-04-12 | by ( Spencer Kimball | ) www.cnbc.com time to read: +3 min

The Alliance Defending Freedom's lead attorney, Erik Baptist, argued in a new filing to the U.S. 5th Circuit Court of Appeals late Tuesday that the court lacks authority to grant the Justice Department's request to block the decision. His decision is set to take effect a 12 a.m. central time on Saturday if the 5th Circuit does not block it. Baptist made a technical argument that Kacsmaryk's decision to suspend the approval date cannot be appealed to the 5th Circuit under federal law, in contrast to an injunction or a final court decision. He argued the case should continue to play out in the U.S. District Court for the Northern District of Texas. They called on the 5th Circuit to immediately block the judge's order from going into effect early Saturday.

☆ Texas judge's ruling suspends FDA approval of abortion pill mifepristone, jeopardizing availability nationwide
▼ + stars: | 2023-04-07 | by ( Michelle Mark | Charles R. Davis | ) www.businessinsider.com time to read: +4 min

Texas Judge Matthew Kacsmaryk issued a ruling Friday that jeopardizes the availability of a key abortion drug. An antiabortion legal group had sought to revoke or suspend the FDA's approval of the drug mifepristone. In the ruling, Judge Matthew Kacsmaryk, who was appointed by former President Donald Trump, imposed a stay on the Food & Drug Administration's approval of the drug, arguing that it was unlawful. Revoking the FDA's approval of mifepristone could immediately upend abortion access for countless women across the country. The medication mifepristone typically works as part of a two-medication regimen to terminate pregnancies.

Adding to the volatile legal landscape around abortion, a federal judge in Washington state on Friday issued a seemingly conflicting injunction that prevented federal regulators from altering access to the same abortion drug. Kacsmaryk's ruling is a preliminary injunction that would essentially ban sales of mifepristone while the case by anti-abortion groups before him continues. By choosing to sue in Amarillo, the plaintiffs ensured that the case would go before Kacsmaryk, a conservative former Christian activist. Circuit Court of Appeals, which has a conservative reputation, with more than two-thirds of its judges appointed by Republican presidents. The FDA in January said that the government for the first time will allow mifepristone to be dispensed at retail pharmacies.

☆ Abortion pill mifepristone ruling in Texas case could hinge on 1873 Comstock Act
▼ + stars: | 2023-03-21 | by ( Spencer Kimball | ) www.cnbc.com time to read: +6 min

A federal judge in Texas may try to invoke an obscure 19th-century law called the Comstock Act to roll back mail delivery of the abortion pill mifepristone. His rationale could hinge in part on the Comstock Act. The anti-abortion group's attorneys argued that the Comstock Act and other laws ban mail delivery of mifepristone. The Comstock Act has not been enforced in decades, said Rachel Rebouche, an expert on reproductive health law at Temple University. Congress passed the Comstock Act in 1873 after an anti-vice crusader named Anthony Comstock successfully lobbied lawmakers to declare "obscene" materials as not mailable.

☆ U.S. judge in Texas will soon rule on the abortion pill mifepristone. Here's what could happen
▼ + stars: | 2023-03-17 | by ( Spencer Kimball | ) www.cnbc.com time to read: +7 min

The Alliance For Hippocratic Medicine wants Judge Kacsmaryk to nullify the FDA's medical approval of mifepristone, which would effectively ban the abortion pill across the US. Senate Judiciary Committee | YouTubeA Texas judge will soon issue a pivotal ruling in a closely watched case challenging the Food and Drug Administration's approval of the abortion pill mifepristone. It's also possible that Kacsmaryk could order the agency to impose tighter restrictions on access to mifepristone but stop short of completely halting sales. Abortion rights groups and legal experts expect the judge will rule against the FDA in some form. Possible injunctionIf Kacsmaryk issues an order to withdraw mifepristone from the market, there are several ways such a ruling could be drafted.

☆ Abortion pill fight: Read the transcript of Texas court hearing on fate of mifepristone
▼ + stars: | 2023-03-17 | by ( Spencer Kimball | ) www.cnbc.com time to read: +1 min

Abortion rights advocates gather in front of the J Marvin Jones Federal Building and Courthouse in Amarillo, Texas, on March 15, 2023. Judge Matthew Kacsmaryk of the U.S. Northern District of Texas in Amarillo heard four hours of arguments. The anti-abortion group that filed the lawsuit, the Alliance Defending Freedom, presented their case against the FDA first. They were followed by Justice Department attorneys defending the FDA and then the abortion pill maker Danco Laboratories. The Alliance Defending Freedom argued that mifepristone is unsafe and the FDA did not properly follow its approval process when it cleared mifepristone for use in 2000.

☆ Texas abortion pill case: Lawyers requesting mifepristone’s removal from market concede there’s no precedent
▼ + stars: | 2023-03-15 | by ( Michelle Mark | ) www.businessinsider.com time to read: +3 min

A Texas lawsuit has demanded that the judge revoke the FDA approval of the abortion pill mifepristone. The group alleged in their lawsuit that the FDA approved an "unsafe" drug back in 2000. During Wednesday's hearing, The Washington Post and Associated Press reported that all parties acknowledged the unprecedented nature of the Alliance Defending Freedom's demand. The attorney representing the Alliance Defending Freedom, Erik Baptist, responded, "No, I can't." Drugs like mifepristone and misoprostol have been thrown into the spotlight ever since the Supreme Court overturned Roe v. Wade last June.

☆ Where Restrictions on Abortion Pills Could Matter Most
▼ + stars: | 2023-03-02 | by ( Allison Mccann | Amy Schoenfeld Walker | ) www.nytimes.com time to read: +10 min

Abortion providers in the United States A United States map shows the location of abortion providers in states without abortion bans. total abortions Medication abortions 71,700 61,500 58% 37,500 32,100 28,800 29,500 41% 61% 60% 51% 52% Florida New York Georgia Pa. Mich. N.C. N.J. Ohio Wash. Mass. Some ways the ruling could affect the availability of abortion pills A flowchart shows possible outcomes from a judge’s ruling and highlights how abortion pills could remain available under some scenarios. Even if the judge rules in favor of the plaintiffs, abortion pills could remain available. The foundation’s Wichita, Kansas, clinic sees more than 500 patients a month, many from Texas, and 60 percent choose abortion pills.

Search resuls for: "Erik Baptist"

12 mentions found